|Articles|July 8, 2022
News Roundup: July 1 to July 8
Author(s)Miranda Hester
Your weekly roundup of the latest news from Drug Topics®.
Advertisement
Pharmacists Authorized by FDA to Prescribe Paxlovid, With Limitations
According to the agency, this new authority may improve access to patients at high risk for severe COVID-19.
Dulaglutide Effective in Children with Type 2 Diabetes
New research indicates dulaglutide is effective in improving glycemic control in pediatric patients with diabetes.
Acne Treatments and Considering Mental Health
The effect of acne is more than skin deep.
Higher Risk for Uncontrolled Hypertension Found in Black Patients with MS
Hypertension adversely impacts the multiple sclerosis (MS) disease course and is more common among Black Americans.
At Least 105 Million Doses of COVID-19 Vaccine for Fall Ordered by HHS
Purchase follows FDA recommendation to include Omicron component in boosters.
Newsletter
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.
Advertisement
Related Content
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
Targeted Coordination Is Crucial in Boosting Pneumococcal Vaccine Coverage
2
CoronaVac Improves Outcomes of COVID-19 for Patients With Schizophrenia
3
Reducing HIV Stigma Can Improve Patient Care, Provider Connectivity
4
Q&A: Pharmacist Highlights Small Lifestyle Changes That Lower A1c
5